Inovio Pharmaceuticals, Inc. (INO)
1.10
+0.01
(+0.92%)
USD |
NASDAQ |
Jun 09, 16:00
1.10
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Research and Development Expense (Quarterly) : 13.75M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| ADMA Biologics, Inc. | 2.597M |
| Agenus, Inc. | 11.82M |
| Vertex Pharmaceuticals, Inc. | 961.60M |
| ACADIA Pharmaceuticals, Inc. | 76.87M |